Health Secretary Wes Streeting has launched an independent review into the prevalence, trends, and clinical management of mental health conditions, attention deficit hyperactivity disorder (ADHD), and ...
Deworming drug, levamisole, is being evaluated by the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) following concerns about its links with leukoencephalopathy.